
ED1000 Treatment: How It Works and What to Expect
A detailed look at the ED1000 low-intensity shockwave device, its session protocol, and realistic success rates, from Dr. Tuncay Tas.
Table of Contents
What Is ED1000 Treatment?
Medispec manufactures the ED1000, a specific low-intensity shockwave device for erectile dysfunction. It delivers focused acoustic energy to the penis. This aims to improve blood flow and support natural erectile function, without medication or any surgical intervention involved.
Shockwave therapy first proved itself in cardiology. Specifically, it treated tissue with poor blood supply after heart damage. The ED1000 brought this same technology to urology. SafeFill Clinic has offered it since 2012. For a broader overview, therefore, see our ESWT Treatment guide.
Unlike some newer shockwave devices still accumulating clinical data, ED1000 carries a longer track record specifically. This matters for patients who want a treatment backed by more than a single promising study, since a longer history of real-world use tends to reveal both benefits and limitations more clearly than short-term trials alone.
Patients traveling to Istanbul for this treatment should plan for multiple visits over several weeks, given the multi-session protocol. Our team helps coordinate accommodation for the full treatment period, so international patients can complete the entire course without needing to travel back and forth repeatedly across separate trips.
How ED1000 Treatment Actually Works
The device focuses and directs shock waves into penile tissue. In cardiology, this same energy stimulates new blood vessel formation in areas with poor circulation. ED1000, therefore, applies the identical principle to the penis.
Successful erections depend directly on adequate blood flow. By encouraging new, small vessels to form, in addition, ED1000 aims to increase that blood supply at its source. This differs from medication, which simply enhances an erection that already exists.
This distinction matters for how patients should think about the treatment. Rather than a temporary fix taken before each intimate encounter, ED1000 works toward addressing the underlying vascular limitation itself, which is why its effects continue well after the treatment course ends, unlike a pill that only works for a few hours at a time.
Curious if ED1000 fits your case?
Dr. Tas reviews your history and explains realistic expectations.
Who Benefits Most From ED1000 Treatment?
ED1000 works specifically for vascular causes of erectile dysfunction. This means cases rooted in poor blood flow, rather than hormonal or purely psychological factors. Vascular causes, in fact, account for roughly 70% of ED cases overall. Diabetics and coronary vascular patients make up the largest group within that.
ED1000 also shows encouraging results around prostate surgery, both before and after. This procedure commonly affects erectile function through nerve and vascular changes near the surgical site.
Conversely, patients whose ED stems primarily from psychological factors or hormonal imbalance, such as low testosterone, typically see less benefit from this specific treatment. During consultation, Dr. Tas assesses which category best describes your case, since the right diagnosis determines which treatment path actually makes sense for your specific situation.
Session Protocols and Success Rates
| Severity | Session Count | Reported Success |
|---|---|---|
| Mild to moderate | 6 to 12 sessions | Roughly 3 out of 4 patients |
| Severe | 12 to 24 sessions | Roughly 2 out of 4 patients |
Mild and moderate patients often reduce or eliminate medication use after 6 to 12 sessions. Severe cases, in contrast, typically need the longer protocol.
Even so, many patients who previously did not respond to medication begin responding afterward. ED1000 carries no reported side effects. Consequently, no fixed ceiling exists on session count, and additional sessions tend to further improve results for patients who need them.
Each session itself takes roughly 20 minutes, and most patients schedule two sessions per week to complete the full protocol within a reasonable timeframe. Dr. Tas adjusts the exact schedule based on your specific severity and how your response develops throughout treatment.
What the Research Actually Shows
Published clinical studies on ED1000 report meaningful symptom improvement in real-world patient groups. A retrospective Japanese study of 76 patients, for example, found significant improvement in sexual symptom scores. This came after 12 sessions over nine weeks.
That said, we believe in giving patients the full picture. Broader reviews of low-intensity shockwave therapy, in addition, note that human-trial evidence remains stronger for some outcomes than others, and results vary across studies. Dr. Tas discusses this honestly during consultation, therefore, rather than promising guaranteed results.
Several international urology associations have included low-intensity shockwave therapy in their treatment guidelines as an option worth considering, particularly for men seeking a non-pharmacological approach. This growing acceptance within the medical community reflects accumulating evidence, even as researchers continue refining exactly which patients benefit most and by how much.
Safety and Side Effects
ED1000 involves no incisions, no medication, and no sedation. To date, the clinic has recorded no reported side effects during or after treatment. There is no pain during the sessions themselves either. Patients return to normal daily activity immediately after each visit, without any restrictions.
This safety profile explains why sessions can extend for more severe cases without added risk. Medication-based approaches, in contrast, carry dose-related concerns that limit how far patients can push them.
Because ED1000 avoids systemic medication entirely, it also suits men who cannot safely take oral ED drugs, such as those on nitrate medication for heart conditions. This makes it a genuinely useful option for a patient group that otherwise has fewer effective treatment paths available to them.
When Results Appear and How Long They Last
Most patients first notice the treatment effect about one month after completing their final session, since new vessel formation takes time. ED1000 entered clinical use worldwide in 2012. Clinical follow-up since then shows benefits continuing for roughly two years in many patients, and longer-term studies are still ongoing to establish precisely how far that benefit extends.
One published study in the Journal of Urology found that low-intensity shockwave therapy works best within the first two years of symptom onset. Effectiveness declines somewhat, however, for long-standing or initially severe dysfunction. For this reason, earlier evaluation tends to produce better outcomes than waiting.
This timing effect makes intuitive sense biologically. Vascular tissue that has adapted to poor blood flow over many years responds less readily to a stimulus encouraging new vessel growth than tissue still in the earlier stages of that same decline, explaining why men noticing early symptoms benefit from prompt evaluation rather than delay in seeking care.

Assoc. Prof. Dr. Tuncay Tas
Board-Certified Urologist & Male Sexual Health Specialist. SafeFill Clinic has offered ED1000 treatment since 2012, and the clinic received certification training from David Simhon, MD, in 2013. Dr. Tas personally evaluates each patient's vascular profile before recommending this treatment specifically, and he explains the expected timeline for results clearly during the initial consultation so patients know what to watch for at each stage.
Frequently Asked Questions
How many sessions does ED1000 treatment require?
Does ED1000 have any side effects?
Who responds best to ED1000?
How long do ED1000 results last?
Is ED1000 the same as general ESWT?
Can ED1000 help after prostate surgery?
Can I use ED1000 if I take heart medication?
How long does each session take?
How long should international patients plan to stay?
Send Us a Message
Ready to Discuss ED1000 Treatment?
Book a confidential consultation with Assoc. Prof. Dr. Tuncay Tas in Istanbul.